Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
0.8640
+0.0645 (8.07%)
At close: Oct 22, 2026, 4:00 PM EDT
0.8498
-0.0142 (-1.64%)
Pre-market: Oct 23, 2026, 4:00 AM EDT
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $3.48 million as of October 22, 2026. It is the 46,259th most valuable company in the world and the 6,165th biggest in the United States. Its market cap has increased by 22.86% in one year.
Market Cap
3.48M
Enterprise Value
-937.63K
1-Year Change
22.86%
Global Rank
Country Rank
#6,165 United States
Category
ChartMarket Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $3.48M, a decrease of -93.95%. That is a compound annual growth rate of -41.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 3.48M | -43.69% |
| Dec 31, 2025 | 6.17M | 124.01% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.38% |
| Dec 30, 2022 | 4.95M | -65.85% |
| Dec 31, 2021 | 14.49M | -74.79% |
| Aug 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cadrenal Therapeutics | 3.71M |
| Jupiter Neurosciences | 3.69M |
| PharmaCyte Biotech | 3.67M |
| KALA BIO | 3.67M |
| Ernexa Therapeutics | 3.66M |
| Addex Therapeutics | 3.58M |
| Moolec Science | 3.33M |
| 60 Degrees Pharmaceuticals | 3.24M |